drugset / Trial / NCT00723021

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

NCT00723021

Phase 2 Completed 15 enrolled Pfizer
RandomizedCrossoverQuadruple-blindTreatment

Summary

Study to determine the bronchodilatory effects of PF-04191834 compared with zileuton in patients with asthma

Timeline

Start
2008-07
Primary completion
2008-12
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-4191834 Small molecule 30 mg Oral
Subject PF-4191834 Small molecule 100 mg Oral
Subject PF-4191834 Small molecule 2000 mg Oral
Comparator Zileuton Small molecule 1200 mg

Indications